Updates
-
-
I Survived My ‘Home Alone’ Weekend
OK, this was my first test. Accomplish this and Day One should be a breeze. The trick is not to panic. You’ve crossed a ... Read more -
Obesity May Prevent First-line MS Therapies from Working in Youngsters, Study Suggests
Obesity may increase the risk for the development and progression of multiple sclerosis (MS) in children and teens, and it may prevent first-line MS ... Read more -
This Is Me, and This Is How I Live with My MS
Have you ever read something and thought, “This is me, this is my MS”? It happened to me today as I read a post ... Read more -
Convelo Therapeutics and Genentech Join Forces to Develop Remyelination Therapies
Convelo Therapeutics has announced a collaboration with Genentech, a member of the Roche Group, to work toward the development of new remyelination therapies for ... Read more -
Need to Know: Managing Stress When You Have MS
Editor’s note: “Need to Know” is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? ... Read more
-
What can changes in grey matter mean for MS? (Sponsored Post)
The brain is made up of two types of tissue: grey matter and white ... -
Specific Lipids in Cerebrospinal Fluid of Progressive MS Patients Rob Neurons of Energy, Study Finds
The cerebrospinal fluid (CSF) of people with progressive multiple sclerosis (MS) contains elevated levels ... -
Higher Doses of Opicinumab as Add-on Therapy Fail to Lessen MS Disability, Phase 2 Trial Shows
Treating people with relapsing forms of multiple sclerosis (MS) with opicinumab and Avonex (interferon beta-1a) ... -
Talking to My Parents About My MS Diagnosis
There is nothing worse than being diagnosed with a disorder that you know nothing ... -
Phase 3 Trial of Ibudilast Planned for SPMS Patients with Inactive Disease, MediciNova Says
A Phase 3 trial is planned to confirm the safety and efficacy of oral ... -
Phase 1 Trial of T20K, Plant Protein-derived Therapy for MS, Doses 1st Group of Healthy Men
A first group of healthy volunteers in a Phase 1 trial assessing the safety ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more